Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flublok Quadrivalent in Healthy Children and Adolescents
NCT03460743Phase 3Completed
- Sponsor
- Laboratorios Liomont
- Start
- Mar 2018
- Primary completion
- Oct 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of influenza vaccine, recombinant hemagglutinin in influenza, sponsored by Laboratorios Liomont. Started Mar 2018; status: completed.
02
Drugs
influenza vaccine, recombinant hemagglutinin
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03460743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03460743.